Tseng, Ping-Hui <br/><br/>
Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance.  [electronic resource] 

 -  Blood  May 2005 
 - 4021-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2004-07-2967  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3-Phosphoinositide-Dependent Protein Kinases<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Benzamides<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Enzyme Activation--drug effects<br/>Fusion Proteins, bcr-abl--genetics<br/>Imatinib Mesylate<br/>Mice<br/>Mutation--genetics<br/>Phosphorylation<br/>Piperazines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-akt<br/>Pyrazoles--pharmacology<br/>Pyrimidines--pharmacology<br/>Signal Transduction--drug effects<br/>Sulfonamides--pharmacology